Evaluation of 18F-PSMA-1007 PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy

Código QR

Evaluation of 18F-PSMA-1007 PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy

Purpose: Prostate-specific membrane antigen (PSMA) ligands targeting has shown promising results in staging of prostate cancer (PCa). The aim of present study was to evaluate the value of 18F-PSMA-1007 PET/CT in PCa patients with biochemical recurrence. Methods: 71 patients with PCa after radical pr...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Xing Zhou, Xiao Jiang, Luzhou Liu, Xiaoxiong Wang, Chuan Li, Yutang Yao, Ying Kou, Jiaqi Shen, Taipeng Shen, Zeng Li, Shengke Yang, Shukui Zhou, Hong Liao, Zhifu Luo, Xiaoai Wu, Shirong Chen, Zhuzhong Cheng
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2022
Materias:	Prostate cancer Prostate-specific membrane antigen Biochemical recurrence Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/af6f41997c3d418ba478c5e2e4a71f83
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Surface-enhanced Raman spectroscopy before radical prostatectomy predicts biochemical recurrence better than CAPRA-S
por: Pan J, et al.
Publicado: (2019)

Phosphatase and Tensin Gene Associated with Features of Aggressive Prostate Cancer
por: Mojtaba Saadati, et al.
Publicado: (2021)

A Prospective Study Assessing the Post-Prostatectomy Detection Rate of a Presumed Local Failure at mpMR with Either <sup>64</sup>CuCl<sub>2</sub> or <sup>64</sup>CuPSMA PET/CT
por: Adriana Faiella, et al.
Publicado: (2021)

Prostate cancer
Publicado: (2011)

Laparoscopic radical prostatectomy and extended pelvic lymph node dissection: a combined technique
por: Piotr Jarzemski, et al.
Publicado: (2020)

Prostate cancer and prostatic diseases
Publicado: (1997)

Blood transfusion had no influence on the 5-year biochemical recurrence after robot-assisted radical prostatectomy: a retrospective study
por: Jiwon Han, et al.
Publicado: (2021)

The prostate journal
Publicado: (1999)

Quantitative [Fe]MRI of PSMA-targeted SPIONs specifically discriminates among prostate tumor cell types based on their PSMA expression levels
por: Sillerud LO
Publicado: (2016)

Low Tumor-to-Stroma Ratio Reflects Protective Role of Stroma against Prostate Cancer Progression
por: Paulina Nastały, et al.
Publicado: (2021)

The first 10 years’ experience in radical retropubic prostatectomy: Complications, lower urinary tract symptoms, and quality of life - a single-center experience
por: Dinić Ljubomir, et al.
Publicado: (2021)

Prostatectomy using different lasers for the treatment of benign prostate hyperplasia in aging males
por: Lee WC, et al.
Publicado: (2013)

Genetic Contributions to Prostate Cancer Disparities in Men of West African Descent
por: Jabril R. Johnson, et al.
Publicado: (2021)

PSMA PET Imaging in Glioblastoma: A Preclinical Evaluation and Theranostic Outlook
por: Maximilian A. Kirchner, et al.
Publicado: (2021)

Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy
por: Karen A. Autio, et al.
Publicado: (2021)

Health-Related Quality of Life following Cytoreductive Radical Prostatectomy in Patients with De-Novo Oligometastatic Prostate Cancer
por: Michael Chaloupka, et al.
Publicado: (2021)

68Ga-PSMA11 PET/CT for biochemically recurrent prostate cancer: Influence of dual-time and PMT- vs SiPM-based detectors
por: Heying Duan, et al.
Publicado: (2022)

Intrapersonal and community factors associated with prostate cancer screening among African-American males in the US
por: Dickey SL, et al.
Publicado: (2016)

An Immune-Related lncRNA Signature to Predict the Biochemical Recurrence and Immune Landscape in Prostate Cancer
por: Zhang G, et al.
Publicado: (2021)

Comparison of <sup>68</sup>Ga-Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography Computed Tomography (PET-CT) and Whole-Body Magnetic Resonance Imaging (WB-MRI) with Diffusion Sequences (DWI) in the Staging of Advanced Prostate Cancer
por: Julien Van Damme, et al.
Publicado: (2021)

Prostate-Specific Membrane Antigen (PSMA) Theranostics for Treatment of Oligometastatic Prostate Cancer
por: Kristin A. Plichta, et al.
Publicado: (2021)

Defining radio-recurrent intra-prostatic target volumes using PSMA-targeted PET/CT and multi-parametric MRI
por: Wei Liu, et al.
Publicado: (2022)

Molecular signature of cancer stem cells isolated from prostate carcinoma and expression of stem markers in different Gleason grades and metastasis
por: Castellón,Enrique A, et al.
Publicado: (2012)

Prostate-Specific Antigen and Testosterone Levels as Biochemical Indicators of Cognitive Function in Prostate Cancer Survivors and the Role of Diabetes
por: Alicja Popiołek, et al.
Publicado: (2021)

Fatty Acid Metabolism Reprogramming in Advanced Prostate Cancer
por: Huan Xu, et al.
Publicado: (2021)

An ambivalent prostate nodule after Bacillus Calmette-Guérin therapy
por: L. Sauvat, et al.
Publicado: (2021)

Effect of training and individual operator's expertise on prostate cancer detection through prostate biopsy: Implications for the current quantitative training evaluation system
por: Dongu Lee, et al.
Publicado: (2021)

High-Dose-Rate Brachytherapy as Monotherapy for Low- and Intermediate-Risk Prostate Cancer. Oncological Outcomes After a Median 15-Year Follow-Up
por: Manuel Behmueller, et al.
Publicado: (2021)

Post-Operative Radiotherapy in Prostate Cancer: Is It Time for a Belt and Braces Approach?
por: Nicolas Giraud, et al.
Publicado: (2021)

PSMA-Targeting Reduction-Cleavable Hyperbranched Polyamide-Amine Gene Delivery System to Treat the Bone Metastases of Prostate Cancer
por: Ye Y, et al.
Publicado: (2020)

Imaging of Neuroendocrine Prostatic Carcinoma
por: Ahmed Taher, et al.
Publicado: (2021)

Cabazitaxel in the treatment of metastatic castration-resistant prostate cancer
por: Nikolai A. Ognerubov
Publicado: (2021)

Preliminary Results of an Ongoing Prospective Clinical Trial on the Use of <sup>68</sup>Ga-PSMA and <sup>68</sup>Ga-DOTA-RM2 PET/MRI in Staging of High-Risk Prostate Cancer Patients
por: Paola Mapelli, et al.
Publicado: (2021)

Initial Experience of Clinical Use of [<sup>99m</sup>Tc]Tc-PSMA-T4 in Patients with Prostate Cancer. A Pilot Study
por: Jarosław B. Ćwikła, et al.
Publicado: (2021)

Highly portable quantitative screening test for prostate-specific antigen at point of care
por: Balaji Srinivasan, et al.
Publicado: (2021)

18F-choline positron emission tomography/computed tomography guided laparoscopic salvage lymph node dissection in patients after radical prostatectomy
por: Markiian Kubis, et al.
Publicado: (2020)

Predicting Cancer-Specific Survival Among Patients With Prostate Cancer After Radical Prostatectomy Based on the Competing Risk Model: Population-Based Study
por: Xianghong Zhou, et al.
Publicado: (2021)

Combined Open Prostatectomy and Kidney Surgery: Feasibility and 12-Month Outcome
por: Rath L, et al.
Publicado: (2021)

Hypoehoic lesions on Transrectal Ultrasound and its correlation to Gleason grade in the diagnosis of Clinically Significant Prostate Cancer: A Prospective Study
por: Manas Sharma, et al.
Publicado: (2021)

PSMA-PET/MRI-Based Focal Dose Escalation in Patients with Primary Prostate Cancer Treated with Stereotactic Body Radiation Therapy (HypoFocal-SBRT): Study Protocol of a Randomized, Multicentric Phase III Trial
por: Constantinos Zamboglou, et al.
Publicado: (2021)